Detalles de la búsqueda
1.
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(5): 503-513, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156478
2.
Nonperturbative Double Copy in Flatland.
Phys Rev Lett
; 129(22): 221602, 2022 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36493434
3.
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.
J Natl Compr Canc Netw
; 20(2): 106-117, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35130502
4.
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents.
Am J Hematol
; 95(7): 792-798, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32242967
5.
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
Clin Infect Dis
; 68(12): 2003-2009, 2019 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30256954
6.
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.
Biol Blood Marrow Transplant
; 25(3): 515-521, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30315941
7.
Dose-related periorbital edema following sorafenib in a patient with acute myeloid leukemia.
J Oncol Pharm Pract
; 25(8): 2035-2037, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30537918
8.
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition.
Invest New Drugs
; 36(4): 657-666, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29607465
9.
Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia.
Haematologica
; 108(12): 3511-3516, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470155
10.
Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey.
Cancer
; 123(3): 449-458, 2017 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27690182
11.
Getting It Right the First Time: Defining Regionally Relevant Training Curricula and Provider Core Competencies for Point-of-Care Ultrasound Education on the African Continent.
Ann Emerg Med
; 69(2): 218-226, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27974170
12.
Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey.
BMC Cancer
; 16: 167, 2016 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26922064
13.
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation.
Am J Hematol
; 91(9): 883-7, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27197602
14.
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.
Am J Hematol
; 91(5): 453-60, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26858124
15.
Approach to patients with primary refractory acute myeloid leukemia.
Curr Opin Hematol
; 22(2): 97-107, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25575037
16.
Acute cholecystitis is a common complication after allogeneic stem cell transplantation and is associated with the use of total parenteral nutrition.
Biol Blood Marrow Transplant
; 21(4): 768-71, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25543093
17.
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning.
Biol Blood Marrow Transplant
; 20(11): 1758-66, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25016197
18.
IDH2-mutated near ETP-ALL with aggressive leukemia cutis and brisk response to venetoclax and decitabine.
Leuk Res Rep
; 21: 100408, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38269085
19.
Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies.
Leuk Lymphoma
; 65(4): 503-510, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38259250
20.
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
Transplant Cell Ther
; 29(2): 113-118, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36336258